Multiple sclerosis drugs on Blue Medicare Rx Enhanced (S5540-004)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), North Carolina
- Premium
- $163.20/month
- Deductible
- None
4 of 8 Multiple sclerosis drugs are covered on this plan. All 4 require prior authorization.
4 aren't on the formulary, including teriflunomide and Mayzent.
- $16,047.74Tier 5
- from $44.56Tier 4
- $3,173.53Tier 5
- $96.19Tier 4
Not on the formulary
teriflunomide, Mayzent, Zeposia, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.